InvestorsHub Logo
Followers 59
Posts 7364
Boards Moderated 0
Alias Born 10/20/2014

Re: Majobuki post# 979

Tuesday, 08/11/2020 6:23:29 PM

Tuesday, August 11, 2020 6:23:29 PM

Post# of 1319
Without any details it is impossible to say. Why they would make the
announcement without providing the substance is beyond me. Perhaps
TRVN wants to raise money to hire its own sales force...that may be
better than a JV because it keeps them open to an eventual BO. I really
do not think any small biopharma should ever "go it alone" once they have
a viable product. Normally, the company will either JV or sell the company. Even if the company says they will hire a sales force it does
not preclude an acquirer if the right deal is brought to the table.
"If" TRVN really does have a potential $1 billion plus product...the
BO value should be a multiple of that (usually 4-5 X peak revenues.)
TRVN has a market cap of under $300 million...so if the share price
wrong? Or is the market saying that the company can't achieve such
a lofty sales goal...even with a BP acquirer. I wish I knew.
This could be a $10 plus share price within a year is decent sales
materialize. (I would rather a BO emerges instead.)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TRVN News